Top

Chinese Journal of Cancer Research

Published in:

01-09-2011 | Case Report

Mosaic trisomy 21 and trisomy 14 as acquired cytogenetic abnormalities without GATA1 mutation in a pediatric non-down syndrome acute megakaryoblastic leukemia

Authors: Yi Xiao, Jia Wei, Jin-huan Xu, Jian-feng Zhou, Yi-cheng Zhang

Published in: Chinese Journal of Cancer Research | Issue 3/2011

Title: Mosaic trisomy 21 and trisomy 14 as acquired cytogenetic abnormalities without GATA1 mutation in a pediatric non-down syndrome acute megakaryoblastic leukemia
Authors: Yi Xiao
Jia Wei
Jin-huan Xu
Jian-feng Zhou
Yi-cheng Zhang
Publication date: 01-09-2011
Publisher: Chinese Anti-Cancer Association
Published in: Chinese Journal of Cancer Research / Issue 3/2011
Print ISSN: 1000-9604
Electronic ISSN: 1993-0631
DOI: https://doi.org/10.1007/s11670-011-0239-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2011

Src is dephosphorylated at tyrosine 530 in human colon carcinomas

High expression of p300 in human breast cancer correlates with tumor recurrence and predicts adverse prognosis

Therapy-related acute myeloid leukemia in a primary pulmonary leiomyosarcoma patient with skin metastasis

XRCC1 polymorphisms and pancreatic cancer: A meta-analysis

Determination of PDCD5 in peripheral blood serum of cancer patients

Oxaliplatin-induced lung injury with allergic reaction

Keynote webinar | Spotlight on antibody–drug conjugates in cancer